HSCS MEXC RealStocks
Own real HSCS shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-16 17:51:00. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
HeartSciences Inc. (HSCS) operates in the FINANCE SERVICES sector and is listed on NASDAQ. The stock is currently priced at $2.06, with a market capitalization of $10.56M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.63 to $5.25. This page covers its latest market performance, valuation, price trends and company information.
$10.56M | |
$2.13 | |
$3.00 | |
$2.05 | |
$2.13 | |
22.40K | |
171.49K | |
-- | |
$5.25 | |
$1.63 | |
-- | |
-- |
HeartSciences Inc. (HSCS) is currently trading at $2.06 as of 2026-11-16 17:46:00, down 4.00% ($0.08) from the previous close of $2.13
During today's regular trading session, HSCS has traded between $2.05 and $3.00, with a trading volume of 22.40K shares. The current price is near the lower end of today's range.
Over the past seven days, HeartSciences Inc. (HSCS) moved from $2.67 to $2.06, representing a decline of 22.85% ($0.61).
The stock traded between $2.04 and $3.09 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 109.99 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 11.9%
HSCS is currently trading at $2.06, placing it 11.9% of the way from its 52-week low of $1.63 to its 52-week high of $5.25. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare setting, either via the MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via the MyoVista wavECG Device.
| Industry | FINANCE SERVICES |
| Employees | 14 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of HeartSciences Inc. (HSCS) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to HSCS, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between HSCS shares and USD.
HSCS Shares to USD
1.00 HSCS shares = 2.06 USD
Calculations are estimates based on the latest available price and are for reference only.